Caxton Associates (New York)’s Maximus MMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,893
Closed -$225K 558
2022
Q3
$225K Buy
+3,893
New +$243K 0.03% 379
2022
Q2
Sell
-10,080
Closed -$755K 675
2022
Q1
$755K Buy
10,080
+2,091
+26% +$160K 0.06% 152
2021
Q4
$636K Buy
+7,989
New +$653K 0.06% 213
2021
Q3
Sell
-5,095
Closed -$448K 534
2021
Q2
$448K Buy
+5,095
New +$467K 0.05% 197
2019
Q3
Sell
-6,000
Closed -$435K 486
2019
Q2
$435K Buy
+6,000
New +$435K 0.05% 215

Other funds holding MMS

Caxton Associates (New York)'s MMS Position: Q4 2022 in Review

Caxton Associates (New York) sold out of Maximus (MMS) in Q4 2022, closing a stake of 3,893 shares — an estimated $225K sold.

Caxton Associates (New York) first reported a position in MMS in Q2 2019 and held it in 5 quarters. The position peaked at $755K in Q1 2022. 306 funds tracked by Wall St. Rank hold MMS as of Q4 2022.

  • Caxton Associates (New York) reported no remaining Maximus position as of Q4 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,893 Maximus shares in Q4 2022, an estimated $225K.
  • Caxton Associates (New York) first reported a position in Maximus in Q2 2019 and held it in 5 quarters.
  • Caxton Associates (New York)'s Maximus position peaked at $755K in Q1 2022.
  • 306 funds tracked by Wall St. Rank held Maximus as of Q4 2022.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.